A detailed history of Intech Investment Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Intech Investment Management LLC holds 22,143 shares of NVCR stock, worth $373,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,143
Holding current value
$373,330
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$15.61 - $23.34 $345,652 - $516,817
22,143 New
22,143 $346,000
Q3 2023

Oct 18, 2024

SELL
$16.15 - $42.35 $92,555 - $242,707
-5,731 Reduced 31.24%
12,614 $203,000
Q3 2023

Nov 13, 2023

SELL
$16.15 - $42.35 $92,555 - $242,707
-5,731 Reduced 31.24%
12,614 $203,000
Q2 2023

Oct 18, 2024

SELL
$40.29 - $82.51 $550,482 - $1.13 Million
-13,663 Reduced 42.69%
18,345 $761,000
Q2 2023

Aug 09, 2023

SELL
$40.29 - $82.51 $550,482 - $1.13 Million
-13,663 Reduced 42.69%
18,345 $761,000
Q1 2023

Oct 18, 2024

BUY
$56.44 - $118.81 $1.81 Million - $3.8 Million
32,008 New
32,008 $1.92 Million
Q1 2023

May 10, 2023

BUY
$56.44 - $118.81 $295,124 - $621,257
5,229 Added 19.53%
32,008 $1.92 Million
Q4 2022

Oct 18, 2024

BUY
$63.98 - $85.37 $1.54 Million - $2.06 Million
24,072 Added 889.25%
26,779 $1.96 Million
Q4 2022

Feb 09, 2023

BUY
$63.98 - $85.37 $1.54 Million - $2.06 Million
24,072 Added 889.25%
26,779 $1.96 Million
Q3 2022

Oct 18, 2024

BUY
$67.99 - $89.57 $184,048 - $242,465
2,707 New
2,707 $205,000
Q3 2022

Nov 10, 2022

SELL
$67.99 - $89.57 $158,960 - $209,414
-2,338 Reduced 46.34%
2,707 $206,000
Q2 2022

Aug 10, 2022

BUY
$56.6 - $89.9 $285,547 - $453,545
5,045 New
5,045 $351,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.77B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.